首页> 外文期刊>Cancer Management and Research >NETO2 promotes pancreatic cancer cell proliferation, invasion and migration via activation of the STAT3 signaling pathway
【24h】

NETO2 promotes pancreatic cancer cell proliferation, invasion and migration via activation of the STAT3 signaling pathway

机译:NetO2通过激活Stat3信号通路促进胰腺癌细胞增殖,侵袭和迁移

获取原文
           

摘要

Purpose: The biological functions of neuropilin and tolloid-like 2 ( NETO2 ) in the progression of pancreatic cancer remained unexplored. We aimed to investigate the biological roles and underlying molecular mechanisms of NETO2 in pancreatic cancer. Materials?and methods: Thirty paired pancreatic tumor tissue samples and corresponding nontumor tissues were obtained from 30 pancreatic cancer patients who did not receive preoperative chemotherapy or radiotherapy. The changes in multiple cellular functions associated with tumor progression were assessed after NETO2 knockdown/overexpression in pancreatic cancer cell lines. Additionally, a mouse-xenograft model was developed to verify the in vitro results. Results: NETO2 was upregulated in pancreatic tumor tissues. Elevated expression of NETO2 was not only associated with an advanced tumor stage, but was also a prediction of poor prognosis for pancreatic cancer patients. Knockdown of NETO2 in pancreatic cancer cell lines arrested the cell cycle and inhibited cell proliferation, colony formation, invasion, and migration; in contrast, overexpression of NETO2 had an opposite effect on all of these parameters. A STAT3 specific inhibitor, cryptotanshinone, reversed the tumor-promoting effects induced by NETO2 overexpression in pancreatic cancer. Western blot analysis showed that invasion and migration were closely related to epithelial–mesenchymal transition, and that the STAT3 signaling pathway was involved in NETO2 -mediated oncogenic transformation in pancreatic cancer cells. Furthermore, NETO2 knockdown significantly inhibited the growth of pancreatic tumor xenografts in nude mice. Conclusion: NETO2 has an important role in the progression and metastasis of pancreatic cancer and could serve as a novel candidate for targeted therapy of pancreatic cancer.
机译:目的:胰腺癌进展中神经素和脱蛋白样2(NetO2)的生物学功能仍未开发。我们旨在探讨NetO2在胰腺癌中的生物作用和潜在的分子机制。材料呢?和方法:从30个胰腺癌患者中获得30个成对的胰腺肿瘤组织样品和相应的无骨骼组织,该癌症患者没有接受术前化疗或放射疗法。在胰腺癌细胞系中NetO2敲低/过度表达后评估与肿瘤进展相关的多种细胞功能的变化。另外,开发了鼠标 - 异种移植模型以验证体外结果。结果:NetO2在胰腺肿瘤组织中上调。 NetO2的升高表达不仅与先进的肿瘤阶段有关,而且还对胰腺癌患者的预后不良的预测。 NetO2敲低在胰腺癌细胞系中捕获细胞周期并抑制细胞增殖,殖民地形成,侵袭和迁移;相比之下,NetO2的过表达对所有这些参数具有相反的影响。 Dat3特异性抑制剂,Cryptotalshinone,逆转了NetO2过表达在胰腺癌中诱导的肿瘤促进作用。 Western印迹分析表明,侵袭和迁移与上皮 - 间充质转换密切相关,并且STAT3信号通路涉及NetO2介导的胰腺癌细胞的致癌转化。此外,NetO2敲低显着抑制裸鼠胰腺肿瘤异种移植物的生长。结论:NetO2在胰腺癌的进展和转移中具有重要作用,可以作为胰腺癌靶向治疗的新候选者。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号